Patient and physician preferences for first‐line treatment of classical Hodgkin lymphoma in Germany, France and the United Kingdom

First‐line treatments for classical Hodgkin lymphoma (HL) include ABVD (adriamycin, bleomycin, vinblastine, dacarbazine) and BEACOPP (escalated) (escalated dose bleomycin, etoposide, adriamycin, cyclophosphamide, vincristine, procarbazine, prednisone). To further improve overall outcomes, positron e...

Descripción completa

Detalles Bibliográficos
Autores principales: Bröckelmann, Paul J., McMullen, Suzanne, Wilson, J Ben, Mueller, Kerstin, Goring, Sarah, Stamatoullas, Aspasia, Zagadailov, Erin, Gautam, Ashish, Huebner, Dirk, Dalal, Mehul, Illidge, Tim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Haematological Malignancy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6585631/
https://www.ncbi.nlm.nih.gov/pubmed/30239982
http://dx.doi.org/10.1111/bjh.15566

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6585631/
https://www.ncbi.nlm.nih.gov/pubmed/30239982
http://dx.doi.org/10.1111/bjh.15566

Ejemplares similares